Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors?

DSpace Repository

Show simple item record

dc.contributor.author Mischinger, Johannes
dc.contributor.author Schwentner, Christian
dc.contributor.author Stenzl, Arnulf
dc.contributor.author Gakis, Georgios
dc.date.accessioned 2016-03-03T14:17:19Z
dc.date.available 2016-03-03T14:17:19Z
dc.date.issued 2015
dc.identifier.issn 1527-2737
dc.identifier.uri http://hdl.handle.net/10900/68697
dc.language.iso en en
dc.publisher Springer de_DE
dc.relation.uri http://dx.doi.org/10.1007/s11934-015-0532-8
dc.rights info:eu-repo/semantics/closedAccess
dc.subject.ddc 610 de_DE
dc.title Inflammation and Cancer: What Can We Therapeutically Expect from Checkpoint Inhibitors? de_DE
dc.type Article de_DE
utue.quellen.id 20151209042647_00831
utue.personen.roh Mischinger, Johannes
utue.personen.roh Comperat, Eva
utue.personen.roh Schwentner, Christian
utue.personen.roh Stenzl, Arnulf
utue.personen.roh Gakis, Georgios
dcterms.isPartOf.ZSTitelID Current Urology Reports de_DE
dcterms.isPartOf.ZS-Issue Article 59 de_DE
dcterms.isPartOf.ZS-Volume 16 de_DE
utue.fakultaet 04 Medizinische Fakultät


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record